Dermatologic Cosmetic Laboratories - Spot Therapy
Natural health product licensed in Canada
- Licence holder
- Dermatologic Cosmetic Laboratories
- NPN or DIN-HM
- 80075210
- Status
- Active licence
- Licence date
- 23 January 2017
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-hydroxybenzoïque Source : Acide salicylique | 2 % |
Non-medicinal ingredients
Lactic acid bacteria, Alcool t-butylique, L-isoleucine, Huile d'Ormenis multicaulis, propylèneglycol, Alcool éthylique, Huile essentielle de Cymbopogon schoenanthus, Hydrolysate de protéines de soya, Extrait de feuilles de Camellia Sinensis, Extrait de lysat de Saccharomyces, Hyaluronate de sodium, Butylène glycol, Hydroxyethyl Cellulose, Extrait de racine de Poterium Officinale, Extrait de Cymbopogon Schoenanthus, L-Valine, Ferment de Saccharomyces/Silicon, Ferment de Saccharomyces/Zinc, Ferment de saccharomyces/fer, L-histidine, extrait de fleur de Lavendula angustifolia (lavande), Eau d'hamamelis virginiana (noisetier de sorcière), D-Panthénole, Hydroxyde de sodium, Aqua, EDTA de sodium, L-thréonine, L-phenylalanine, pentylene glycol, Lactate de sodium, extrait de graine de kolatier, Acide L-aspartique, Ferment de Saccharomyces/Magnésium, L-Alanine, alcool spécialement dénaturé 40B (ou SDA 40B), PCA de sodium, PEG-40 Hydrogenated Castor Oil, Farnésol, Niacinamide, Métabisulfite de sodium, Extrait d'écorce de cinnamomum cassia, Extrait d'Echinacea purpurea, L-arginine, Extrait de fleur/feuille/tige d'Epilobium Angustifolium, palmitate de rétinyle, Glycine, Glycérine, Vitamine E, Extrait de racine de Glycyrrhiza glabra (Réglisse), Ferment de Saccharomyces/Cuivre, Phénoxyéthanol, Pyrus malus (apple) fruit extract, Extrait de racine de zingiber officinale (Gingembre), Coconut Acid, L-sérine, Bisabolol, L-proline, PPG-26-Buteth-26
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 0.5 millilitre ; maximum: 1 millilitre | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Treatment of Acne
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80075210
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.